Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
168
Views
5
CrossRef citations to date
0
Altmetric
Short Report

Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study

Claire Hopkins1 Department of Otorhinolaryngology – Head and Neck Surgery, Guy’s and St Thomas’ NHS Foundation Trust, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3993-1569View further author information
ORCID Icon,
Kathleen M Buchheit2 Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-5977-851XView further author information
ORCID Icon,
Enrico Heffler3 Personalized Medicine, Asthma & Allergy – Humanitas Clinical and Research Center IRCCS, Milan, Italy;4 Department of Biomedical Sciences, Humanitas University, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-0492-5663View further author information
ORCID Icon,
Noam A Cohen5 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USAORCID Iconhttps://orcid.org/0000-0003-2600-6710View further author information
ORCID Icon,
Heidi Olze6 Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Berlin, GermanyORCID Iconhttps://orcid.org/0000-0001-9987-6392View further author information
ORCID Icon,
Asif H Khan7 Global Medical Affairs, Sanofi, Chilly-Mazarin, FranceORCID Iconhttps://orcid.org/0000-0001-9158-0116View further author information
ORCID Icon,
Jérôme Msihid8 Health Economics and Value Assessment, Sanofi, Chilly-Mazarin, FranceORCID Iconhttps://orcid.org/0000-0003-4733-5855View further author information
ORCID Icon,
Shahid Siddiqui9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
,
Scott Nash9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
,
Juby A Jacob-Nara10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAORCID Iconhttps://orcid.org/0000-0002-5372-8762View further author information
ORCID Icon,
Paul J Rowe10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAView further author information
&
Yamo Deniz9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
 show all
Pages 767-773 | Published online: 07 Jun 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, Joseph K Han, Nicole Martin, Elliot Israel, Jason K Lee, Jean-Pierre Llanos, Neil Martin, Ayman Megally, Bhavini Parikh, Sylvia Vong, Tobias Welte & Jonathan Corren. (2023) Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR. Journal of Asthma and Allergy 16, pages 915-932.
Read now

Articles from other publishers (4)

Subhabrata Moitra, Ana Adan, Metin Akgün, Augustus Anderson, Amanda Brickstock, Allie Eathorne, Ali Farshchi Tabrizi, Prasun Haldar, Linda Henderson, Aditya Jindal, Surinder Kumar Jindal, Bugra Kerget, Fadi Khadour, Lyle Melenka, Saibal Moitra, Tanusree Moitra, Rahul Mukherjee, Alex Semprini, Alice M. Turner, Nicola Murgia, Giovanni Ferrara & Paige Lacy. (2023) Less Social Deprivation Is Associated With Better Health-Related Quality of Life in Asthma and Is Mediated by Less Anxiety and Better Sleep Quality. The Journal of Allergy and Clinical Immunology: In Practice 11:7, pages 2115-2124.e7.
Crossref
D. A. Sivokhin, E. S. Shchennikova, V. V. Royuk & N. P. Kniajeskaia. (2023) Dupilumab in complex therapy for chronic rhinosinusitis with nasal polyps and asthma. Meditsinskiy sovet = Medical Council:7, pages 203-208.
Crossref
Christian Korsgaard Pedersen, Christiane Haase, Kasper Aanaes, Christian von Buchwald & Vibeke Backer. (2023) An update on patient reported outcomes in type 2 inflammation airway disease. Current Opinion in Allergy & Clinical Immunology 23:1, pages 1-8.
Crossref
Ulrike Förster-Ruhrmann, Dafni Stergioudi, Agnieszka J. Szczepek, Joachim W. Fluhr, Torsten Zuberbier, Heidi Olze & Karl-Christian Bergmann. (2023) A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics. World Allergy Organization Journal 16:2, pages 100746.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.